IMPORTANT SAFETY INFORMATION: PRASCEND is for use in horses only. Treatment with PRASCEND may cause loss of
appetite. Most cases are mild. Weight loss, lack of energy, and behavioral changes also may be observed. If severe, a temporary
dose reduction may be necessary. PRASCEND has not been evaluated in breeding, pregnant, or lactating horses and may interfere
with reproductive hormones in these horses. PRASCEND Tablets should not be crushed due to the potential for increased human
exposure. Refer to package insert for complete product information.
Decreased athletic performance. Change in attitude.
Abnormal sweating. Regional hypertrichosis.
Regional adiposity. Tendonitis.
These are a few of the early signs associated with PPID.
If you've recognized any of these signs in your clients'
horses, no matter the age, consider testing for PPID.
With timely diagnosis and Prascend
®
(pergolide tablets),
PPID can be effectively managed so that your clients'
horses may lead long, happy, productive lives.
Visit PRASCEND.com to learn more
about the clinical signs of PPID in horses.
®
PRASCEND is a registered trademark of Boehringer Ingelheim GmbH, licensed to
Boehringer Ingelheim Vetmedica, Inc. ©2018 Boehringer Ingelheim Vetmedica, Inc.
All rights reserved. EQU-0515-PRAS0418
Recognize the early
signs associated with
PPID for early diagnosis.
